20year survival after radical prostatectomy as initial treatment for cT3
... series of 235 men with cT3 prostate cancer treated with RP. Of these men, 22% received adjuvant and 34% received salvage treatments. Nonetheless, with a relatively short follow-up (5.8 years), actuarial 10-year prostate cancer survival was 91.6%. In the present series, despite nodal metastases in ≈2 ...
... series of 235 men with cT3 prostate cancer treated with RP. Of these men, 22% received adjuvant and 34% received salvage treatments. Nonetheless, with a relatively short follow-up (5.8 years), actuarial 10-year prostate cancer survival was 91.6%. In the present series, despite nodal metastases in ≈2 ...
Title Human prostate cancer progression models and therapeutic
... exhibited an Androgen- and estrogen-Repressed Prostate Cancer cell growth and tumor formation in either a hormone-deficient or a castrated environment. However, the growth of either the tumor cells in vitro or the tumors in vivo was suppressed by both estrogen and androgen. While the tumor cells exp ...
... exhibited an Androgen- and estrogen-Repressed Prostate Cancer cell growth and tumor formation in either a hormone-deficient or a castrated environment. However, the growth of either the tumor cells in vitro or the tumors in vivo was suppressed by both estrogen and androgen. While the tumor cells exp ...
Introducing the Next Generation of Prostate Cancer
... Primary Tumor (T) - Clinical • * Note: Tumor found in one or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c. • ** Note: Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified not as T3 but as T2. ...
... Primary Tumor (T) - Clinical • * Note: Tumor found in one or both lobes by needle biopsy, but not palpable or reliably visible by imaging, is classified as T1c. • ** Note: Invasion into the prostatic apex or into (but not beyond) the prostatic capsule is classified not as T3 but as T2. ...
Submission To Health Select Committee: Early Detection and
... detection of prostate cancer before having any form of testing. The discussion should also include possible treatment options, including active surveillance, and any associated side effects should the result be positive. It should be noted that side effects from early treatment have significantly re ...
... detection of prostate cancer before having any form of testing. The discussion should also include possible treatment options, including active surveillance, and any associated side effects should the result be positive. It should be noted that side effects from early treatment have significantly re ...
Letter to F State Legislators
... killed nearly 50,000 people last year in the U.S. Half of those who succumb to the disease are women. What many people don’t realize is that this second-leading cancer killer is highly preventable-and 90 percent treatable when detected early with appropriate screening. In fact, the colon cancer deat ...
... killed nearly 50,000 people last year in the U.S. Half of those who succumb to the disease are women. What many people don’t realize is that this second-leading cancer killer is highly preventable-and 90 percent treatable when detected early with appropriate screening. In fact, the colon cancer deat ...
Patient-reported outcome measures in metastatic prostate cancer
... rostate cancer is the most common male cancer in the UK. In 2012, 43 400 men were diagnosed with and 10 800 men died from this cancer in the UK.1 It has been estimated that approximately 10% of men diagnosed with prostate cancer present with advanced or metastatic disease. In addition, other men rel ...
... rostate cancer is the most common male cancer in the UK. In 2012, 43 400 men were diagnosed with and 10 800 men died from this cancer in the UK.1 It has been estimated that approximately 10% of men diagnosed with prostate cancer present with advanced or metastatic disease. In addition, other men rel ...
NHS England Cancer Taskforce call to evidence Tackle Prostate
... curable stage. The high death rate represents not only a personal disaster for over 10,000 men who die every year, but also a great burden on the Health Service in terms of palliative care costs (e.g. long term hormone treatment and chemotherapy). There is often increased anxiety amongst men with ri ...
... curable stage. The high death rate represents not only a personal disaster for over 10,000 men who die every year, but also a great burden on the Health Service in terms of palliative care costs (e.g. long term hormone treatment and chemotherapy). There is often increased anxiety amongst men with ri ...
Observation in the Management of Localized Prostate Cancer
... in considering observation as a management option for all men with newly diagnosed prostate cancer and suggested that most men with prostate cancer with a life expectancy of greater than 10 to 15 years should be treated with curative intent. Two additional reports from Scandinavia also temper the th ...
... in considering observation as a management option for all men with newly diagnosed prostate cancer and suggested that most men with prostate cancer with a life expectancy of greater than 10 to 15 years should be treated with curative intent. Two additional reports from Scandinavia also temper the th ...
Cancer blood test?
... • A 55 y/o male “new patient” comes in for a routine physical. • They ask you to order “all the cancer blood tests so they will know if they are going to get cancer” • They tell you that many of their aunts, uncles, and cousins have had assorted different cancers. ...
... • A 55 y/o male “new patient” comes in for a routine physical. • They ask you to order “all the cancer blood tests so they will know if they are going to get cancer” • They tell you that many of their aunts, uncles, and cousins have had assorted different cancers. ...
The Prostate Cancer Prevention Trial and Its - EU-ACME
... be reduced to 262,567. The authors of the report estimate that for each absolute increase of 5% in the proportion of patients with high-grade tumours, the number of person-years saved would be reduced by approximately 39,000. They concluded that the results of the PCPT would have a major impact on p ...
... be reduced to 262,567. The authors of the report estimate that for each absolute increase of 5% in the proportion of patients with high-grade tumours, the number of person-years saved would be reduced by approximately 39,000. They concluded that the results of the PCPT would have a major impact on p ...
Do All Patients with Newly Diagnosed Prostate Cancer Need
... predicting the presence of bone metastases at diagnosis which indicate that not only PSA but also other clinical variables such as clinical stage and Gleason score should be considered (18). Gleave et al. (20) mentioned that the negative predictive value of clinical T stage was insignificant to iden ...
... predicting the presence of bone metastases at diagnosis which indicate that not only PSA but also other clinical variables such as clinical stage and Gleason score should be considered (18). Gleave et al. (20) mentioned that the negative predictive value of clinical T stage was insignificant to iden ...
Prostate Cancer: Transrectal Ultrasound Guided Prostate Biopsy
... TRUS alone should not be used as a first-line screening study as it lacks acceptable specificity, is relatively expensive when compared with digital rectal examination (DRE) and prostate specific antigen (PSA) testing and adds little information to that already gained by the use of serum PSA and dig ...
... TRUS alone should not be used as a first-line screening study as it lacks acceptable specificity, is relatively expensive when compared with digital rectal examination (DRE) and prostate specific antigen (PSA) testing and adds little information to that already gained by the use of serum PSA and dig ...
Efficacy of Using Sequential Primary Circulating Prostate Cell
... according to the criteria of ISHAGE (International Society of Hemotherapy and Genetic Engineering) (Borgen et al, 1999) and the expression of P504S according to the Consensus of the American Association of Pathologists (Rubin et al., 2001). A CPC was defined as a cell that expressed PSA and P504S, a ...
... according to the criteria of ISHAGE (International Society of Hemotherapy and Genetic Engineering) (Borgen et al, 1999) and the expression of P504S according to the Consensus of the American Association of Pathologists (Rubin et al., 2001). A CPC was defined as a cell that expressed PSA and P504S, a ...
Whole Body MR for Visualizing Metastatic Prostate Cancer PDF
... and a false negative metastatic ...
... and a false negative metastatic ...
Coop student advert May 2013 APCRC-Q
... Prostate cancer is the second most commonly diagnosed cancer, and second leading cause of cancer death in men. The Australian Prostate Cancer Research Centre – Queensland (APCRC – Q) is an integrated, trans-disciplinary, and comprehensive prostate cancer research centre based in the state-of-the-art ...
... Prostate cancer is the second most commonly diagnosed cancer, and second leading cause of cancer death in men. The Australian Prostate Cancer Research Centre – Queensland (APCRC – Q) is an integrated, trans-disciplinary, and comprehensive prostate cancer research centre based in the state-of-the-art ...
PHS 398 (Rev. 9/04), Biographical Sketch
... research projects. In summary, I have a demonstrated record of successful and productive research projects in an area that has significant impact on prostate cancer management that affect 1 in 6 men, and my expertise and experience have prepared me to lead the proposed project. B. Positions and Hono ...
... research projects. In summary, I have a demonstrated record of successful and productive research projects in an area that has significant impact on prostate cancer management that affect 1 in 6 men, and my expertise and experience have prepared me to lead the proposed project. B. Positions and Hono ...
Phase II study of mitoxantrone and ketoconazole for hormone
... associated with response rates of 30% to 40%, Sella et al.13 reported that the combination of doxorubicin plus ketoconazole was associated with a response rate of 55% in a hormone-refractory cohort. In addition, objective responses were observed in 7 of 12 patients (58%) with measurable soft tissue ...
... associated with response rates of 30% to 40%, Sella et al.13 reported that the combination of doxorubicin plus ketoconazole was associated with a response rate of 55% in a hormone-refractory cohort. In addition, objective responses were observed in 7 of 12 patients (58%) with measurable soft tissue ...
